Adenotonsillectomy for upper respiratory infections: evidence based?

Background: Despite high rates of (adeno)tonsillectomy for upper respiratory infections in western countries, the medical literature offers the physician little support in deciding which child might benefit from the operation. Methods: A literature search was performed to identify randomised trials...

Full description

Saved in:
Bibliographic Details
Published inArchives of disease in childhood Vol. 90; no. 1; pp. 19 - 25
Main Authors van Staaij, B K, van den Akker, E H, van der Heijden, G J M G, Schilder, A G, Hoes, A W
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health 01.01.2005
BMJ
BMJ Publishing Group Ltd
BMJ Publishing Group LTD
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Despite high rates of (adeno)tonsillectomy for upper respiratory infections in western countries, the medical literature offers the physician little support in deciding which child might benefit from the operation. Methods: A literature search was performed to identify randomised trials and non-randomised controlled studies into the efficacy of tonsillectomy with or without adenoidectomy in children under 18 years. For the outcomes sore throat episodes, sore throat associated school absence, and upper respiratory infections, pooled estimates of the incidence rate ratios and rate differences with 95% confidence intervals were calculated, assuming a Poisson distribution. Results: Six randomised trials and seven non-randomised controlled studies on the efficacy of adenotonsillectomy in children were evaluated. For sore throat episodes data for 2483 person-years were available. The pooled risk difference was −1.2 episodes per person-year (95% CI −1.3 to −1.1). For sore throat associated school absence 1669 person-years were analysed. The pooled risk difference was −2.8 days per person-year (95% CI −3.9 to −1.6). For upper respiratory infections 1596 person-years were available. The pooled risk difference was −0.5 episodes per person-year (95% CI −0.7 to −0.3). Conclusions: All available randomised trials and non-randomised controlled studies into the efficacy of (adeno)tonsillectomy had important limitations. The frequency of sore throat episodes and upper respiratory infections reduces with time whether (adeno)tonsillectomy has been performed or not. (Adeno)tonsillectomy gives an additional, but small, reduction of sore throat episodes, days of sore throat associated school absence, and upper respiratory infections compared to watchful waiting
Bibliography:Correspondence to:
 Mrs B K van Staaij
 University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, location Stratenum 6.131, Universiteitsweg 100, 3584 CG Utrecht, Netherlands; B.K.vanStaaij@med.uu.nl
istex:0E5E71B4A3B60DD13F717270E338BA7602453F66
ark:/67375/NVC-JRKSL7NB-F
href:archdischild-90-19.pdf
PMID:15613505
local:0900019
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0003-9888
1468-2044
DOI:10.1136/adc.2003.047530